Sectors
BIAF
bioAffinity Technologies, Inc.
4.56
2 x 3.48
2 x 6.02
bid
ask
-
0.31
6.37%
2 @ 05:31 PM
4.61 +0.05 (1.10%)
| Ytd | 286.44% | |
| 1y | -37.19% |
4.56
day range
4.98
4.56
52 week range
202.50
| Open | 4.83 | Prev Close | 4.87 | Low | 4.56 | High | 4.98 | Mkt Cap | 2.70M |
| Vol | 36.05K | Avg Vol | 220.82K | EPS | -1.35 | P/E | N/A | Forward P/E | -1.58 |
| Beta | 3.12 | Short Ratio | 1.43 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 9.36 | 200-d Avg | 22.65 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 1.51M | ||
| Revenues (USD) | 1.51M | ||
| Cost of Revenue | 1.09M | ||
| Gross Profit | 422.74K | ||
| Operating Expenses | 3.76M | ||
| Research and Development Expense | 361.58K | ||
| Selling, General and Administrative Expense | 2.86M | ||
| Operating Income | -3.33M | ||
| Interest Expense | 11.69K | ||
| Net Income | -3.37M | ||
| Net Income Common Stock | -3.37M | ||
| Net Income Common Stock (USD) | -3.37M | ||
| Consolidated Income | -3.37M | ||
| Earnings per Basic Share | -9.60 | ||
| Earnings per Basic Share (USD) | -9.60 | ||
| Earnings per Diluted Share | -9.60 | ||
| Earning Before Interest & Taxes (EBIT) | -3.35M | ||
| Earning Before Interest & Taxes (USD) | -3.35M | ||
| Weighted Average Shares | 348.45K | ||
| Weighted Average Shares Diluted | 348.45K | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.43M | ||
| Cash and Equivalents (USD) | 2.43M | ||
| Trade and Non-Trade Receivables | 894.82K | ||
| Current Assets | 3.87M | ||
| Property, Plant & Equipment Net | 1.65M | ||
| Total Assets | 7.62M | ||
| Debt Current | 265.43K | ||
| Total Debt | 1.44M | ||
| Current Liabilities | 2.68M | ||
| Debt Non-Current | 1.17M | ||
| Total Liabilities | 3.85M | ||
| Accumulated Retained Earnings (Deficit) | -75.55M | ||
| Shareholders Equity | 3.77M | ||
| Shareholders Equity (USD) | 3.77M | ||
| Assets Non-Current | 3.75M | ||
| Total Debt (USD) | 1.44M | ||
| Deferred Revenue | 31.14K | ||
| Goodwill and Intangible Assets | 2.09M | ||
| Inventory | 82.38K | ||
| Liabilities Non-Current | 1.17M | ||
| Trade and Non-Trade Payables | 969.85K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 61.56K | ||
| Net Cash Flow from Financing | 2.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -668.65K | ||
| Capital Expenditure | -89.97K | ||
| Issuance (Purchase) of Equity Shares | 2.69M | ||
| Issuance (Repayment) of Debt Securities | -66.12K | ||
| Net Cash Flow from Investing | -89.97K | ||
| Net Cash Flow from Operations | -3.20M | ||
| Share Based Compensation | 784.94K | ||